Nuvectis Pharma, Inc.
NVCT
$18.96
-$0.27-1.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.29% | -15.85% | 70.69% | 106.43% | 47.90% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.93% | -5.63% | 1.35% | 5.07% | 17.58% |
| Total Current Assets | -17.15% | -15.76% | 70.41% | 105.62% | 47.60% |
|
|
|||||
| Total Current Assets | -17.15% | -15.76% | 70.41% | 105.62% | 47.60% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -17.15% | -15.76% | 70.41% | 105.62% | 47.60% |
|
|
|||||
| Total Accounts Payable | 4.16% | 56.92% | 151.16% | 184.79% | 169.61% |
| Total Accrued Expenses | 32.24% | 9.84% | 9.79% | 24.86% | 29.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,750.67% | -- | -- | -- | -- |
| Total Other Current Liabilities | 1,750.67% | -- | -- | -- | -- |
| Total Current Liabilities | 31.17% | 21.58% | 49.49% | 83.30% | 75.65% |
|
|
|||||
| Total Current Liabilities | 31.17% | 21.58% | 49.49% | 83.30% | 75.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.17% | 21.58% | 49.49% | 83.30% | 75.65% |
|
|
|||||
| Common Stock & APIC | 19.70% | 20.52% | 42.36% | 49.23% | 35.04% |
| Retained Earnings | -32.79% | -34.56% | -36.10% | -37.88% | -35.11% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -46.17% | -32.14% | 89.57% | 118.45% | 34.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.17% | -32.14% | 89.57% | 118.45% | 34.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -46.17% | -32.14% | 89.57% | 118.45% | 34.67% |
|
|
|||||